Advertisement · 728 × 90
#
Hashtag
#Elanco_Animal_Health
Advertisement · 728 × 90
Preview
Elanco Animal Health's Strong Q4 and Full Year 2025 Results with Upsurge in Innovation Goals In its recent report, Elanco Animal Health detailed strong financial results for Q4 and full year 2025, driven by innovation and growth, along with ambitious targets for 2026.

Elanco Animal Health's Strong Q4 and Full Year 2025 Results with Upsurge in Innovation Goals #United_States #Elanco_Animal_Health #Indianapolis #Credelio_Quattro #Befrena

0 0 0 0
Preview
Elanco Animal Health to Engage Investors at Major Upcoming Conferences Elanco Animal Health sets to participate in key investor conferences between late February and March, featuring top executives in discussions that matter.

Elanco Animal Health to Engage Investors at Major Upcoming Conferences #Elanco_Animal_Health #Investor_Conferences #Jeff_Simmons

0 0 0 0
Preview
Elanco Animal Health Announces Key Changes in Board Leadership and Strategic Direction Elanco has announced significant changes within its Board of Directors, including retirements of key figures. Read on for insights.

Elanco Animal Health Announces Key Changes in Board Leadership and Strategic Direction #United_States #Elanco_Animal_Health #Indianapolis #R._David_Hoover #Deborah_Kochevar

0 0 0 0
Preview
Elanco Animal Health Releases Strong Q3 2025 Results with Increased Outlook and Innovation Targets Elanco Animal Health showcases impressive Q3 2025 results, highlighting a revenue increase and strengthened innovation targets for the remainder of the year.

Elanco Animal Health Releases Strong Q3 2025 Results with Increased Outlook and Innovation Targets #United_States #Elanco_Animal_Health #Indianapolis #Credelio_Quattro #Experior

0 0 0 0
Preview
Elanco Animal Health Joins S&P MidCap 400; Sarepta Enters S&P SmallCap 600 Elanco Animal Health will replace Sarepta Therapeutics in the S&P MidCap 400, reflecting strategic shifts within major stock indices effective September 2, 2025.

Elanco Animal Health Joins S&P MidCap 400; Sarepta Enters S&P SmallCap 600 #United_States #New_York #Elanco_Animal_Health #Sarepta_Therapeutics #Berkshire_Hills_Bancorp

0 0 0 0
Preview
Elanco Animal Health to Showcase Innovations at Morgan Stanley Healthcare Conference 2025 Elanco Animal Health will attend the Morgan Stanley 23rd Annual Global Healthcare Conference, bringing insights on animal health advancements and innovations.

Elanco Animal Health to Showcase Innovations at Morgan Stanley Healthcare Conference 2025 #United_States #Elanco_Animal_Health #Healthcare_Conference #Greenfield #Animal_Health

0 0 0 0
Preview
Elanco Animal Health Reports Strong Q2 2025 Results with Increased Revenue and Innovation Targets Elanco Animal Health announces impressive Q2 2025 financial performance, elevating revenue and innovation targets while enhancing their leverage ratio outlook.

Elanco Animal Health Reports Strong Q2 2025 Results with Increased Revenue and Innovation Targets #United_States #Elanco_Animal_Health #financial_results #Greenfield #Credelio_Quattro

0 0 0 0
Preview
Neurizon and Elanco Team Up to Propel NUZ-001 Global Commercialization Efforts Neurizon Therapeutics strikes an exclusive deal with Elanco Animal Health, enhancing the path for NUZ-001's commercialization. This agreement accelerates the development of innovative treatments for neurodegenerative diseases.

Neurizon and Elanco Team Up to Propel NUZ-001 Global Commercialization Efforts #USA #Elanco_Animal_Health #Melbourne #NUZ-001 #Neurizon_Therapeutics

0 0 0 0
Preview
Elanco's Groundbreaking Report Unveils Urgent Need for Itch Relief in Dogs Nationwide Elanco's new report reveals a staggering 90% of dogs in the U.S. suffer from itchiness, emphasizing the critical need for effective relief solutions.

Elanco's Groundbreaking Report Unveils Urgent Need for Itch Relief in Dogs Nationwide #United_States #Elanco_Animal_Health #Zentrelia #Itchy_Dogs #Greenfield,_IN

0 0 0 0
Preview
Elanco Animal Health Welcomes Robert VanHimbergen as New CFO to Drive Growth Elanco Animal Health has appointed Robert VanHimbergen as Chief Financial Officer effective July 7, aiming to enhance company growth and innovation.

Elanco Animal Health Welcomes Robert VanHimbergen as New CFO to Drive Growth #USA #Elanco_Animal_Health #Chief_Financial_Officer #Robert_VanHimbergen #Greenfield,_Indiana

0 0 0 0
Preview
Elanco Animal Health Delivers Strong Q1 Results and Optimistic 2025 Forecast Elanco Animal Health has reported a 1% revenue drop in Q1 2025, but remains optimistic with an upward revision in its annual revenue guidance, driven by favorable currency effects.

Elanco Animal Health Delivers Strong Q1 Results and Optimistic 2025 Forecast #United_States #Elanco_Animal_Health #Greenfield #Zenrelia #Credelio_Quattro

0 0 0 0
Preview
Elanco Sells Lotilaner Rights to Blackstone, Boosting Financial Strategy Elanco Animal Health's recent sale of lotilaner rights to Blackstone enables significant debt reduction and enhances its financial positioning in the market.

Elanco Sells Lotilaner Rights to Blackstone, Boosting Financial Strategy #USA #Elanco_Animal_Health #Greenfield #Blackstone_Credit #Lotilaner

0 0 0 0
Preview
Elanco Collaborates with Medgene to Bring Avian Influenza Vaccine to Dairy Cattle Industry Elanco Animal Health and Medgene have partnered to introduce a vaccine for highly pathogenic avian influenza for dairy cattle, enhancing biosecurity.

Elanco Collaborates with Medgene to Bring Avian Influenza Vaccine to Dairy Cattle Industry #United_States #Elanco_Animal_Health #Greenfield #Avian_Influenza #Medgene

0 0 0 0
Preview
Elanco Animal Health to Highlight Innovations in Upcoming Investor Conferences Elanco Animal Health Incorporated announces its participation in several investor conferences, showcasing its commitment to innovation and animal health.

Elanco Animal Health to Highlight Innovations in Upcoming Investor Conferences #United_States #Elanco_Animal_Health #Greenfield #investor_conference #Animal_Health

0 0 0 0
Preview
Elanco Animal Health to Join J.P. Morgan Healthcare Conference in January 2025 Elanco Animal Health will take part in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing their commitment to animal health advancements.

Elanco Animal Health to Join J.P. Morgan Healthcare Conference in January 2025 #United_States #Elanco_Animal_Health #Healthcare_Conference #Greenfield #J.P._Morgan

0 0 0 0
Preview
Legal Concerns for Investors of Elanco Animal Health as Lawsuit Looms A recent lawsuit against Elanco Animal Health Incorporated has raised concerns among investors, particularly regarding FDA approval timelines for Zenrelia and Credelio Quattro.

Legal Concerns for Investors of Elanco Animal Health as Lawsuit Looms #USA #San_Diego #Elanco_Animal_Health #Zenrelia #Credelio_Quattro

1 0 0 0
Preview
Class Action Lawsuit Filed Against Elanco Animal Health as Stakeholders Seek Justice Investors in Elanco Animal Health Incorporated are being urged to join a class action lawsuit over alleged securities fraud, with a December 2024 deadline.

Class Action Lawsuit Filed Against Elanco Animal Health as Stakeholders Seek Justice #United_States #New_York #Class_Action #Elanco_Animal_Health #Levi_Korsinsky

0 0 0 0
Preview
Investors of Elanco Animal Health Should Rally for Class Action Leadership Elanco Animal Health investors have a deadline to lead a class action lawsuit. Learn how to participate and the key details about the case.

Investors of Elanco Animal Health Should Rally for Class Action Leadership #United_States #New_York #Elanco_Animal_Health #Rosen_Law_Firm #Securities_Class_Action

0 0 0 0
Preview
Faruqi & Faruqi, LLP Takes Action for Investors of Elanco Animal Health Amid Controversy Faruqi & Faruqi, LLP is reminding shareholders of Elanco Animal Health about potential claims amidst an investigation into recent troubling disclosures about safety and business forecasts.

Faruqi & Faruqi, LLP Takes Action for Investors of Elanco Animal Health Amid Controversy #United_States #New_York #Elanco_Animal_Health #Faruqi_&_Faruqi #securities_litigation

0 0 0 0
Preview
Investors Urged to Join Class Action Against Elanco Animal Health for Financial Losses Shareholders of Elanco Animal Health who suffered losses are invited to join a class action lawsuit facilitated by The Gross Law Firm.

Investors Urged to Join Class Action Against Elanco Animal Health for Financial Losses #USA #New_York #Elanco_Animal_Health #Gross_Law_Firm #class_action_lawsuit

0 0 0 0
Preview
Shareholder Alert: Class Action Lawsuit Filed Against Elanco Animal Health Over Securities Violations A class action lawsuit has been filed against Elanco Animal Health, impacting investors who purchased shares within the specified class period. Details regarding deadlines for participation are included.

Shareholder Alert: Class Action Lawsuit Filed Against Elanco Animal Health Over Securities Violations #USA #New_York #Class_Action #Elanco_Animal_Health #Pomerantz_Law_Firm

0 0 0 0
Preview
Elanco Animal Health Faces Class Action Lawsuit: Important Information for Investors Levi & Korsinsky LLP has initiated a class action lawsuit against Elanco Animal Health, informing investors of their rights and next steps in this case.

Elanco Animal Health Faces Class Action Lawsuit: Important Information for Investors #United_States #New_York #Class_Action #Levi_&_Korsinsky #Elanco_Animal_Health

0 0 0 0
Preview
Elanco Animal Health Investors Urged to Join Class Action for Recovery Amid Securities Allegations Investors who faced losses with Elanco Animal Health are encouraged to join a class action lawsuit aimed at recovering damages due to alleged securities fraud.

Elanco Animal Health Investors Urged to Join Class Action for Recovery Amid Securities Allegations #United_States #New_York #Class_Action #Elanco_Animal_Health #Securities_Fraud

0 0 0 0
Preview
Investors of Elanco Animal Health Can Take Charge in Class Action Suit Elanco Animal Health investors have an opportunity to lead a class action lawsuit due to misleading statements during a critical period.

Investors of Elanco Animal Health Can Take Charge in Class Action Suit #USA #New_York #Elanco_Animal_Health #Rosen_Law_Firm #Shareholder_Rights

0 0 0 0
Preview
Investors Urged to Act Quickly Ahead of Elanco Class Action Deadline Robbins LLP has alerted investors about an upcoming deadline for a class action lawsuit against Elanco Animal Health. If you acquired shares during the specified period, you may want to take action.

Investors Urged to Act Quickly Ahead of Elanco Class Action Deadline #None #Class_Action #Robbins_LLP #Elanco_Animal_Health

0 0 0 0
Preview
Elanco Animal Health to Showcase Strategies at Upcoming Investor Conferences Elanco Animal Health is set to engage with investors at notable upcoming conferences, highlighting its innovative strategies in the animal health sector.

Elanco Animal Health to Showcase Strategies at Upcoming Investor Conferences #United_States #Elanco_Animal_Health #Investor_Conferences #Todd_Young #Greenfield

0 0 0 0
Preview
Shareholders of Elanco Animal Health Face Class Action Lawsuit and Important Deadline A class action lawsuit has been filed against Elanco Animal Health, urging shareholders to register by December 6, 2024, to participate in potential recovery.

Shareholders of Elanco Animal Health Face Class Action Lawsuit and Important Deadline #USA #New_York #Class_Action #Elanco_Animal_Health #Gross_Law_Firm

0 0 0 0